<--- Back to Details
First PageDocument Content

Anisina’s History of Community Support Novogen’s lead anti-tropomyosin (ATM) drug candidate, Anisina, is in the unusual position of having a history of strong community support throughout its development. The anti-tr

Add to Reading List

Source URL: www.novogen.com

Download Document from Source Website

File Size: 449,00 KB

Share Document on Facebook

Similar Documents